Basic Information
Basic information for LINC01278-229-32aa
Peptide Name LINC01278-229-32aa
Genome Position chrX:63432364-63432411,63517035-63517082[-]
Species Human
Peptide Sequence MSKSSYLILYAFLCSQVLQPWFQSGKHCRPGC
Peptide Length 32
Unique No (LINC01278-205-32aa,LINC01278-210-32aa,LINC01278-211-32aa-1,LINC01278-213-32aa,LINC01278-218-32aa,LINC01278-223-32aa-1,LINC01278-225-32aa,LINC01278-228-32aa-1)
Grand Average of Hydropathicity 0.1
Relative Molecular Mass 4237.8
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000235437;LINC01278
Transcript ID/Name ENST00000666891;LINC01278-229
Transcript Length 1113
Coding Ability 0.2785
DNA Sequence Corresponding to Peptide ATGAGCAAAAGTTCCTATCTAATATTATATGCTTTCCTTTGCTCCCAGGTCCTGCAACCCTGGTTCCAGTCTGGCAAGCATTGTAGACCTGGCTGC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :